Overview

Efficacy Study of Intravenous Iron Preparation to Iron Deficiency Anemia

Status:
Completed
Trial end date:
2018-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to confirm the non-inferiority of Z-213 compared to Saccharated Ferric Oxide using the maximum change in Hb from baseline over 12 weeks in patients with Iron-deficiency Anemia (IDA)
Phase:
Phase 3
Details
Lead Sponsor:
Zeria Pharmaceutical
Treatments:
Ferric Compounds
Ferric Oxide, Saccharated